Biosynthesis of O-Glcnac

Total Page:16

File Type:pdf, Size:1020Kb

Biosynthesis of O-Glcnac DEFINING THE INTERACTOME AND FUNCTIONAL REGULATION OF THE O-GLCNACASE ENZYME DURING OXIDATIVE STRESS by Jennifer A. Groves A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland October, 2017 Abstract The essential post-translational modification O-linked β-N-acetylglucosamine (O- GlcNAc) regulates thousands of nuclear, cytoplasmic, and mitochondrial proteins. O- GlcNAc is dynamically added and removed from proteins by the O-GlcNAc transferase (OGT) and the O-GlcNAcase (OGA), respectively. Dysregulation of O-GlcNAc-cycling is implicated in the etiology of numerous diseases, including cancer, neurodegeneration, and metabolic dysfunction. Underpinning these observations, O-GlcNAc regulates nearly every major cellular process including transcription, translation, protein degradation, protein localization, and the cell cycle. Furthermore, many forms of cellular stress and injury, including oxidative stress, elicit an increase in O-GlcNAcylation on numerous proteins, which has been demonstrated to promote cell survival. However, the mechanisms by which OGT and OGA are regulated during oxidative stress to alter O-GlcNAcylation are not fully characterized. Here, we demonstrate that oxidative stress leads to elevated O- GlcNAc levels in U2OS cells but has little impact on the activity of OGT. In contrast, the expression and activity of OGA are enhanced. We hypothesized that this seeming paradox could be explained by proteins that bind to and control the local activity or substrate targeting of OGA, thereby resulting in the observed stress-induced elevations of O- GlcNAc. To identify potential protein partners and regulators, we utilized BioID proximity biotinylation in combination with Stable Isotopic Labeling of Amino Acids in Cell Culture (SILAC). This analysis revealed 90 OGA-interacting partners, many of which exhibited increased binding to OGA upon stress. The associations of OGA with fatty acid synthase (FAS), filamin-A, heat shock cognate 70 kDa protein, and OGT were confirmed by co- immunoprecipitation. The pool of OGA bound to FAS demonstrated a substantial (∼85%) ii reduction in specific activity, suggesting that FAS inhibits OGA. Consistent with this observation, FAS overexpression augmented stress-induced O-GlcNAcylation on a subset of proteins. Although the mechanism by which FAS sequesters OGA remains unknown, these data suggest that FAS fine-tunes the cell's response to stress and injury by remodeling cellular O-GlcNAcylation. Finally, our studies characterized the use of two commercially available and three non-commercially available antibodies for detecting and enriching full- length OGA from lysates of mouse and human origin in order to facilitate future studies probing the regulation of OGA in disease. Dissertation Advisor: Natasha E. Zachara, Ph.D. Dissertation Reader: Steven M. Claypool, Ph.D. iii Preface My goals for graduate school were to strengthen my knowledge of biological life science and medical research at a molecular level, learn a broad range of techniques and skills that would apply to numerous career paths, and to develop meaningful friendships and a long-lasting professional network. My success in each of these areas is a direct result of the help and support of a number of individuals. First and foremost, I am incredibly grateful that Dr. Natasha E. Zachara gave me the opportunity to train in her laboratory. Natasha fostered my development into a confident and independent scientist, never wavered on her support of my non-academic career goals, and went above and beyond to help in times of personal need. I would also like to thank the members of my thesis committee, Dr.’s Ronald Schnaar, Robert Cole, Katherine Wilson, and Steven Claypool, for their insight, suggestions, and support of my professional goals. Furthermore, I would like to thank my formal and informal collaborators, Dr.’s Jennifer Van Eyk, Akhilesh Pandey, Alfredo Quiñones-Hinojosa, Partha Banerjee, Gerald Hart, Michael Wolfgang, and Sagar Shah, as well as Robert O’Meally, Caitlyn Bowman, and Chris Saeui, for their contributions to this work and my professional development. This work was supported by grants from the National Institutes of Health, including a pre-doctoral National Research Service Award from the National Institute on Aging. I would also like to acknowledge all past and current members of the Zachara laboratory, especially Dr.’s Albert Lee, Kamau Fahie, Marissa Martinez, Devin Miller, Thiago Dias, and Russell Reeves, as well as Gokben Yildirir, Cathrine McKen, Roger Henry, Peter Natov, Srona Sengupa, and Austin Maduka. These individuals have become iv part of my family, providing scientific and technical guidance as well as friendship and laughter during the hardships of graduate school. None of this work could have been successful without the efforts of the Biological Chemistry Department Graduate Program and Administrative Office, especially Darlene Sutton, Danelle Daniels, and Natalie Peters. Finally, I would like to thank my family for their support of my career that took me thousands of miles across the country, and for their faith that I will reach any goal I set my mind to. v Table of Contents ABSTRACT ................................................................................................................................................................. II PREFACE .................................................................................................................................................................. IV TABLE OF CONTENTS .......................................................................................................................................... VI LIST OF TABLES .................................................................................................................................................. VIII LIST OF FIGURES ................................................................................................................................................... IX ABBREVIATIONS ..................................................................................................................................................... X AMINO ACID CODES ........................................................................................................................................... XIII CHAPTER 1: : DYNAMIC O-GLCNACYLATION AND ITS ROLES IN THE CELLULAR STRESS RESPONSE AND HOMEOSTASIS .......................................................................................................................... 1 SUMMARY ...................................................................................................................................................................................... 2 INTRODUCTION ............................................................................................................................................................................. 3 BIOSYNTHESIS OF O-GLCNAC .................................................................................................................................................... 5 The hexosamine biosynthetic pathway ......................................................................................................................... 6 O-GlcNAc transferase ............................................................................................................................................................ 7 O-GlcNAcase ............................................................................................................................................................................ 10 O-GLCNAC AND THE CELLULAR STRESS RESPONSE .............................................................................................................. 11 The PI3K/Akt pathway ....................................................................................................................................................... 14 Heat shock protein expression ........................................................................................................................................ 15 Calcium homeostasis ........................................................................................................................................................... 18 Reactive oxygen species ..................................................................................................................................................... 19 Mitochondrial dynamics .................................................................................................................................................... 20 Inflammation .......................................................................................................................................................................... 22 INTERPLAY BETWEEN O-GLCNAC AND OTHER PTMS ........................................................................................................ 23 Phosphorylation .................................................................................................................................................................... 23 Other PTM roles ..................................................................................................................................................................... 26 MOLECULAR MECHANISMS OF DISEASE ..................................................................................................................................
Recommended publications
  • The Effects of Acute Nicotinamide Riboside Supplementation
    THE EFFECTS OF ACUTE NICOTINAMIDE RIBOSIDE SUPPLEMENTATION ON SUBSTRATE UTILISATION AND 5KM TIME-TRIAL PERFORMANCE By ELIZABETH LOUISE GRAY A thesis submitted to The University of Birmingham for the degree of MASTERS BY RESEARCH School of Sport, Exercise and Rehabilitation Sciences College of Life and Environmental Studies University of Birmingham August 2018 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. ABSTRACT Nicotinamide Riboside (NR) administration has been shown to increase fat oxidation and improve endurance performance in rodents, whilst recent research has proven it is safe for human consumption. The present study aimed to investigate the influence of acute NR supplementation on substrate utilisation and exercise performance in humans. In this counter-balanced, crossover design study, eleven recreationally-active males performed a 60-minute bout of cycling at 55% VO2max, followed by a 5km time-trial. Participants completed this twice during visits separated by at least one week, once following the consumption of 1000mg NR, and the other following placebo consumption. The contribution of fat oxidation to total substrate utilisation was not significantly different between the NR and placebo conditions during steady-state exercise (22.3±9.0% and 19.6±7.3%, respectively; p < 0.05).
    [Show full text]
  • Deamidation of Human Proteins
    Deamidation of human proteins N. E. Robinson*† and A. B. Robinson‡ *Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125; and ‡Oregon Institute of Science and Medicine, Cave Junction, OR 97523 Communicated by Frederick Seitz, The Rockefeller University, New York, NY, August 31, 2001 (received for review May 8, 2001) Deamidation of asparaginyl and glutaminyl residues causes time- 3D structure is known (23). This method is more than 95% dependent changes in charge and conformation of peptides and reliable in predicting relative deamidation rates of Asn residues proteins. Quantitative and experimentally verified predictive cal- within a single protein and is also useful for the prediction of culations of the deamidation rates of 1,371 asparaginyl residues in absolute deamidation rates. a representative collection of 126 human proteins have been It is, therefore, now possible to compute the expected deami- performed. These rates suggest that deamidation is a biologically dation rate of any protein for which the primary and 3D relevant phenomenon in a remarkably large percentage of human structures are known, except for very long-lived proteins. These proteins. proteins require measurement of the 400 Gln pentapeptide rates. in vivo deamidation ͉ asparaginyl residues Materials and Methods Calculation Method. The Brookhaven Protein Data Bank (PDB) eamidation of asparaginyl (Asn) and glutaminyl (Gln) was searched to select 126 human proteins of general biochem- Dresidues to produce aspartyl (Asp) and glutamyl (Glu) ical interest and of known 3D structure without bias toward any residues causes structurally and biologically important alter- known data about their deamidation, except for 13 proteins (as ations in peptide and protein structures.
    [Show full text]
  • Deamidation, Acylation and Proteolysis of a Model Peptide in PLGA Films ⁎ M.L
    Journal of Controlled Release 112 (2006) 111–119 www.elsevier.com/locate/jconrel Deamidation, acylation and proteolysis of a model peptide in PLGA films ⁎ M.L. Houchin a, K. Heppert b, E.M. Topp a, a Department of Pharmaceutical Chemistry, The University of Kansas, 2095 Constant Ave., Lawrence, KS 66047, United States b Higuchi Biosciences Centers, The University of Kansas, Lawrence, KS, United States Received 8 December 2005; accepted 30 January 2006 Available online 9 March 2006 Abstract The relative rates of deamidation, acylation and proteolysis (i.e. amide bond cleavage) were determined for a model peptide (VYPNGA) in poly (DL-lactide-co-glycolide) films. Films were stored at 70°C and either 95%, 75%, 60%, 45%, 28%, or ∼0% relative humidity and at 37°C and 95% relative humidity. Peptide degradation products were identified by ESI+MS/MS and quantitated by LC/MS/MS. Extensive overlap of degradation mechanisms occurred, producing a complex mixture of products. Acylation was the dominant peptide degradation reaction (10–20% of total peptide) at early stages of PLGA hydrolysis and at intermediate relative humidity (60–45% RH). Deamidation and proteolysis were dominant (25–50% and 20–40% of total peptide, respectively) at later stages and at high relative humidity (95–75% RH). Understanding the relative rates of each peptide degradation reaction will allow for improved design of PLGA formulations that preserve the stability of peptide and protein drugs. © 2006 Elsevier B.V. All rights reserved. Keywords: PLGA; Deamidation; Acylation; Proteolysis; Peptide stability 1. Introduction bonds produces lactic and glycolic acid, which are easily metabolized.
    [Show full text]
  • Nobel Lecture by Roger Y. Tsien
    CONSTRUCTING AND EXPLOITING THE FLUORESCENT PROTEIN PAINTBOX Nobel Lecture, December 8, 2008 by Roger Y. Tsien Howard Hughes Medical Institute, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0647, USA. MOTIVATION My first exposure to visibly fluorescent proteins (FPs) was near the end of my time as a faculty member at the University of California, Berkeley. Prof. Alexander Glazer, a friend and colleague there, was the world’s expert on phycobiliproteins, the brilliantly colored and intensely fluorescent proteins that serve as light-harvesting antennae for the photosynthetic apparatus of blue-green algae or cyanobacteria. One day, probably around 1987–88, Glazer told me that his lab had cloned the gene for one of the phycobilipro- teins. Furthermore, he said, the apoprotein produced from this gene became fluorescent when mixed with its chromophore, a small molecule cofactor that could be extracted from dried cyanobacteria under conditions that cleaved its bond to the phycobiliprotein. I remember becoming very excited about the prospect that an arbitrary protein could be fluorescently tagged in situ by genetically fusing it to the phycobiliprotein, then administering the chromophore, which I hoped would be able to cross membranes and get inside cells. Unfortunately, Glazer’s lab then found out that the spontane- ous reaction between the apoprotein and the chromophore produced the “wrong” product, whose fluorescence was red-shifted and five-fold lower than that of the native phycobiliprotein1–3. An enzyme from the cyanobacteria was required to insert the chromophore correctly into the apoprotein. This en- zyme was a heterodimer of two gene products, so at least three cyanobacterial genes would have to be introduced into any other organism, not counting any gene products needed to synthesize the chromophore4.
    [Show full text]
  • BOSTON UNIVERSITY SCHOOL of MEDICINE Dissertation
    BOSTON UNIVERSITY SCHOOL OF MEDICINE Dissertation DEAMIDATION AND RELATED PROBLEMS IN STRUCTURAL ANALYSIS OF PEPTIDES AND PROTEINS by NADEZDA P. SARGAEVA B.S., St. Petersburg State Polytechnical University, 2002 M.S., St. Petersburg State Polytechnical University, 2004 Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy 2012 Approved by First Reader Peter B. O’Connor, Ph.D. Associate Professor of Biochemistry Second Reader Cheng Lin, Ph.D. Assistant Professor of Biochemistry Dedications I dedicate this thesis to my Family iii Acknowledgments I would like to express my deepest gratitude to my advisor, Prof. Peter B. O’Connor. We met in St. Petersburg, Russia in 2004 and you believed in my abilities and you gave me an opportunity to be a part of such a great mass spectrometry program. I also want to thank you for your support and your guidance throughout my Ph.D. studies. Thank you for pushing me to achieve my goals of learning and becoming a better scientist, and for the opportunity you gave me to build up my professional and scientific network. Your help, your advice, and your encouragement in building up my professional career are very much appreciated. Prof. Cheng Lin, thank you for being my second reader and mentor. Working with you has always been a pleasure – I highly value your well thought out ideas, your constant use of the scientific principle, and your willingness to follow up regarding the data, the future directions, etc. I truly appreciate your attention to details, your regular availability and willingness to help me hands on.
    [Show full text]
  • Comparative Analysis of High-Throughput Assays of Family-1 Plant Glycosyltransferases
    International Journal of Molecular Sciences Article Comparative Analysis of High-Throughput Assays of Family-1 Plant Glycosyltransferases Kate McGraphery and Wilfried Schwab * Biotechnology of Natural Products, Technische Universität München, 85354 Freising, Germany; [email protected] * Correspondence: [email protected]; Tel.: +49-8161-712-912; Fax: +49-8161-712-950 Received: 27 January 2020; Accepted: 21 March 2020; Published: 23 March 2020 Abstract: The ability of glycosyltransferases (GTs) to reduce volatility, increase solubility, and thus alter the bioavailability of small molecules through glycosylation has attracted immense attention in pharmaceutical, nutraceutical, and cosmeceutical industries. The lack of GTs known and the scarcity of high-throughput (HTP) available methods, hinders the extrapolation of further novel applications. In this study, the applicability of new GT-assays suitable for HTP screening was tested and compared with regard to harmlessness, robustness, cost-effectiveness and reproducibility. The UDP-Glo GT-assay, Phosphate GT Activity assay, pH-sensitive GT-assay, and UDP2-TR-FRET assay were applied and tailored to plant UDP GTs (UGTs). Vitis vinifera (UGT72B27) GT was subjected to glycosylation reaction with various phenolics. Substrate screening and kinetic parameters were evaluated. The pH-sensitive assay and the UDP2-TR-FRET assay were incomparable and unsuitable for HTP plant GT-1 family UGT screening. Furthermore, the UDP-Glo GT-assay and the Phosphate GT Activity assay yielded closely similar and reproducible KM, vmax, and kcat values. Therefore, with the easy experimental set-up and rapid readout, the two assays are suitable for HTP screening and quantitative kinetic analysis of plant UGTs. This research sheds light on new and emerging HTP assays, which will allow for analysis of novel family-1 plant GTs and will uncover further applications.
    [Show full text]
  • Chem331 Glycogen Metabolism
    Glycogen metabolism Glycogen review - 1,4 and 1,6 α-glycosidic links ~ every 10 sugars are branched - open helix with many non-reducing ends. Effective storage of glucose Glucose storage Liver glycogen 4.0% 72 g Muscle glycogen 0.7% 245 g Blood Glucose 0.1% 10 g Large amount of water associated with glycogen - 0.5% of total weight Glycogen stored in granules in cytosol w/proteins for synthesis, degradation and control There are very different means of control of glycogen metabolism between liver and muscle Glycogen biosynthetic and degradative cycle Two different pathways - which do not share enzymes like glycolysis and gluconeogenesis glucose -> glycogen glycogenesis - biosynthetic glycogen -> glucose 1-P glycogenolysis - breakdown Evidence for two paths - Patients lacking phosphorylase can still synthesize glycogen - hormonal regulation of both directions Glycogenolysis (glycogen breakdown)- Glycogen Phosphorylase glycogen (n) + Pi -> glucose 1-p + glycogen (n-1) • Enzyme binds and cleaves glycogen into monomers at the end of the polymer (reducing ends of glycogen) • Dimmer interacting at the N-terminus. • rate limiting - controlled step in glycogen breakdown • glycogen phosphorylase - cleavage of 1,4 α glycosidic bond by Pi NOT H2O • Energy of phosphorolysis vs. hydrolysis -low standard state free energy change -transfer potential -driven by Pi concentration -Hydrolysis would require additional step s/ cost of ATP - Think of the difference between adding a phosphate group with hydrolysis • phosphorylation locks glucose in cell (imp. for muscle) • Phosphorylase binds glycogen at storage site and the catalytic site is 4 to 5 glucose residues away from the catalytic site. • Phosphorylase removes 1 residue at a time from glycogen until 4 glucose residues away on either side of 1,6 branch point – stericaly hindered by glycogen storage site • Cleaves without releasing at storage site • general acid/base catalysts • Inorganic phosphate attacks the terminal glucose residue passing through an oxonium ion intermediate.
    [Show full text]
  • Supplementary Information
    Supplementary information (a) (b) Figure S1. Resistant (a) and sensitive (b) gene scores plotted against subsystems involved in cell regulation. The small circles represent the individual hits and the large circles represent the mean of each subsystem. Each individual score signifies the mean of 12 trials – three biological and four technical. The p-value was calculated as a two-tailed t-test and significance was determined using the Benjamini-Hochberg procedure; false discovery rate was selected to be 0.1. Plots constructed using Pathway Tools, Omics Dashboard. Figure S2. Connectivity map displaying the predicted functional associations between the silver-resistant gene hits; disconnected gene hits not shown. The thicknesses of the lines indicate the degree of confidence prediction for the given interaction, based on fusion, co-occurrence, experimental and co-expression data. Figure produced using STRING (version 10.5) and a medium confidence score (approximate probability) of 0.4. Figure S3. Connectivity map displaying the predicted functional associations between the silver-sensitive gene hits; disconnected gene hits not shown. The thicknesses of the lines indicate the degree of confidence prediction for the given interaction, based on fusion, co-occurrence, experimental and co-expression data. Figure produced using STRING (version 10.5) and a medium confidence score (approximate probability) of 0.4. Figure S4. Metabolic overview of the pathways in Escherichia coli. The pathways involved in silver-resistance are coloured according to respective normalized score. Each individual score represents the mean of 12 trials – three biological and four technical. Amino acid – upward pointing triangle, carbohydrate – square, proteins – diamond, purines – vertical ellipse, cofactor – downward pointing triangle, tRNA – tee, and other – circle.
    [Show full text]
  • Glycogenosis Due to Liver and Muscle Phosphorylase Kinase Deficiency
    Pediat. Res. 15: 299-303 (198 1) genetics muscle glycogenosis phosphorylase kinase deficiency liver Glycogenosis Due to Liver and Muscle Phosphorylase Kinase Deficiency N. BASHAN. T. C. IANCU. A. LERNER. D. FRASER, R. POTASHNIK. AND S. W. MOSES'"' Pediatric Research Laborarorv. Soroka Medical Center. Iaculr~of Health Sciences. Ben-Gurion Universi!,' of Negev. Beer-Sheva, and Department of Pediatrics. Carmel Hospiral. Huifa. Israel Summary hepatomegaly. The family history disclosed that two sisters were similarly affected, whereas one older brother was apparently A four-year-old Israeli Arab boy was found to have glycogen healthy. accumulation in both liver and muscle without clinical symptoms. Past history was unremarkable. The patient's height was below Liver phosphorylase kinase (PK) activity was 20% of normal, the third percentile for his age in contrast to a normal weight. He resulting in undetectable activity of phosphorylase a. Muscle PK had a doll face and a protuberant abdomen. The liver was palpable activity was about 25% of normal, resulting in a marked decrease 9 cm below the costal margin. Slight muscular hypotonia and of phosphorylase a activity. weakness were noticeable with normal tendon reflexes. He had Two sisters showed a similar pattern, whereas one brother had slightly abnormal liver function tests. a fasting blood sugar of 72 normal PK activity. The patient's liver protein kinase activity was mg %, a normal glucagon test. and no lactic acidemia or uricemia normal. Addition of exogenous protein kinase did not affect PK but slight lipidemia. Electronmicroscopic studies of a liver biopsy activity, whereas exogenous PK restored phosphorylase activity revealed marked deposition of glycogen.
    [Show full text]
  • Deamidation in Moxetumomab Pasudotox Leading to Conformational Change And
    bioRxiv preprint doi: https://doi.org/10.1101/761635; this version posted September 8, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Deamidation in Moxetumomab Pasudotox Leading to Conformational Change and Immunotoxin Activity Loss X. Lu, S. Lin, N. De Mel, A. Parupudi, M. Pandey, J. Delmar, X. Wang, and J. Wang Running Title: Deamidation impacts immunotoxin activity 1 bioRxiv preprint doi: https://doi.org/10.1101/761635; this version posted September 8, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. ABSTRACT Asparagine deamidation is a common posttranslational modification in which asparagine is converted to aspartic acid or isoaspartic acid. By introducing a negative charge, deamidation could potentially impact the binding interface and biological activities of protein therapeutics. We identified a deamidation variant in moxetumomab pasudotox, an immunotoxin Fv fusion protein drug derived from a 38-kilodalton (kDa) truncated Pseudomonas exotoxin A (PE38) for the treatment of hairy-cell leukemia. Although the deamidation site, Asn-358, was outside of the binding interface, the modification had a significant impact on the biological activity of moxetumomab pasudotox. Surprisingly, the variant eluted earlier than its unmodified form on anion exchange chromatography, which suggests a higher positive charge.
    [Show full text]
  • Modeling the Deamidation of Asparagine Residues Via Succinimide Intermediates
    J Mol Model (2001) 7:147–160 DOI 10.1007/s008940100025 ORIGINAL PAPER F. Aylin (Sungur) Konuklar · Viktorya Aviyente Taner Zafer Sen · Ivet Bahar Modeling the deamidation of asparagine residues via succinimide intermediates Received: 29 June 2000 / Accepted: 22 March 2001 / Published online: 24 May 2001 © Springer-Verlag 2001 Abstract Density functional theory (B3LYP/6-31G*) Asp) in a ratio of 1:3. [6] In addition, small amounts of has been used to study the cyclization, deamidation and D-aspartic acid and D-isoaspartic acid were observed, in- hydrolysis reactions of a model peptide. Single point en- dicating slow racemization of the cyclic imide. ergy calculations with the polarized continuum model Spontaneous deamidation through the cyclization drastically lower the activation energy for cyclization in mechanism has been implicated in the inactivation of a a basic medium. Confirmation of the experimental re- number of enzymes. [7] The deamidation reaction has a sults that cyclization is slower than deamidation in acidic much shorter half-life than that for peptide bond hydroly- media and the opposite is true in basic media has enabled sis, varying from days to weeks depending on the amino us to propose mechanisms for both processes. acid sequence. [3] Antibodies that catalyze the deamida- tion and β-aspartyl shift of modified asparaginyl–glycyl Keywords Deamidation · Succinimide · Density dipeptides have been reported. [8] Two classes of anti- functional theory · Hydrolysis of peptides bodies that control theisoaspartate to aspartate product ra- tio were generated. One class catalyzes only the hydroly- sis of succinimide and the other catalyzes both the rate- Introduction limiting deamidation and the subsequent succinimide hy- drolysis.
    [Show full text]
  • Can the Fact That Myelin Proteins Are Old and Break Down Explain the Origin of Multiple Sclerosis in Some People?
    Journal of Clinical Medicine Review Can the Fact That Myelin Proteins Are Old and Break down Explain the Origin of Multiple Sclerosis in Some People? Roger J. W. Truscott * and Michael G. Friedrich Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW 2522, Australia; [email protected] * Correspondence: [email protected]; Tel.: +61-2-4298-3503; Fax: +61-2-4221-8130 Received: 11 July 2018; Accepted: 12 September 2018; Published: 14 September 2018 Abstract: Recent discoveries may change the way that multiple sclerosis (MS) is viewed, particularly with regard to the reasons for the untoward immune response. The fact that myelin proteins are long-lived, and that by the time we are adults, they are extensively degraded, alters our perspective on the reasons for the onset of autoimmunity and the origin of MS. For example, myelin basic protein (MBP) from every human brain past the age of 20 years, is so greatly modified, that it is effectively a different protein from the one that was laid down in childhood. Since only a subset of people with such degraded MBP develop MS, a focus on understanding the mechanism of immune responses to central nervous system (CNS) antigens and cerebral immune tolerance appear to be worthwhile avenues to explore. In accord with this, it will be productive to examine why all people, whose brains contain large quantities of a “foreign antigen”, do not develop MS. Importantly for the potential causation of MS, MBP from MS patients breaks down differently from the MBP in aged controls. If the novel structures formed in these MS-specific regions are particularly antigenic, it could help explain the origin of MS.
    [Show full text]